The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy.

Seervai, Riyad N H; Friske, Sarah K; Chu, Emily Y; Phillips, Rhea; Nelson, Kelly C; Huen, Auris; Cho, Woo Cheal; Aung, Phyu P; Torres-Cabala, Carlos A; Prieto, Victor G; Curry, Jonathan L

Seervai, Riyad N H; Friske, Sarah K; Chu, Emily Y; Phillips, Rhea; Nelson, Kelly C; Huen, Auris; Cho, Woo Cheal; Aung, Phyu P; Torres-Cabala, Carlos A; Prieto, Victor G; Curry, Jonathan L.

Afiliação

Seervai RNH; Internal Medicine Residency Program, Providence Portland Medical Center, Portland, Oregon, USA.
Friske SK; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
Chu EY; Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Phillips R; Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Nelson KC; Department of Dermatology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Huen A; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cho WC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Aung PP; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Curry JL; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

J Cutan Pathol ; 50(1): 72-95, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36069496

Assuntos

Antineoplásicos Imunológicos; Toxidermias; Neoplasias; Humanos; Anticorpos Monoclonais/uso terapêutico; Anticorpos Monoclonais Humanizados/efeitos adversos; Estudos Retrospectivos; Estudos Prospectivos; Antineoplásicos Imunológicos/uso terapêutico; Toxidermias/patologia; Neoplasias/tratamento farmacológico

Palavras-chave

cutaneous adverse events; dermatologic toxicities; monoclonal antibodies; oncologic dermatology; targeted cancer therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxidermias / Antineoplásicos Imunológicos / Neoplasias Limite: Humans Idioma: En Revista: J Cutan Pathol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google